Uncategorized - February 16, 2015
Alzheimer’s Therapy Shows Promise
Scientists at Karolinska Institutet have reviewed a new Alzheimer’s therapy in which the patients receive an implant that stimulates the growth of a type of nerve cell. The results, which are published in the scientific journal ‘Alzheimer’s & Dementia’, suggest that the introduction of a nerve growth factor can prevent neuronal degradation in Alzheimer’s patients. […]
Uncategorized - February 13, 2015
Nerve Pressure at Root of Painful Affliction
About half of patients suffering from one of the most painful disorders ever identified — trigeminal neuralgia– have blood vessels in the brain that apply severe pressure to the main sensory nerve of the face, according to a recent Danish study. Using certain scanning technology, doctors soon may be able to assess whether blood vessel […]
In a new job - February 12, 2015
InDex Appoints New CEO
Peter Zerhouni has been named the new CEO of InDex Pharmaceuticals and is scheduled to take office April 1. He will succeed Jesper Wiklund, who has led the company since 2011. Wiklund has decided to leave InDex Pharmaceuticals to serve as Managing Director Europe at Oberland Capital, a life science focused investment firm based in […]
Uncategorized - February 12, 2015
Simpler Ebola Test in Works
A new Ebola test under development by a team of European scientists will make it possible to screen people where they live–eliminating the risk of infection during a long ambulance journey to a field hospital. “If you don’t already have Ebola, then you’re certain to have caught it after a trip in the ambulance,” says […]
Uncategorized - February 11, 2015
Modz Creates Angry Birds™ Themed Meter
Finnish company Modz has designed an Angry Birds™ themed blood glucose meter for children with Type 1 diabetes that gives them points and rewards for testing regularly. With video game qualities, the meter uses different game levels and points to motivate children to remember to test. Regular testing is critical for diabetics to ensure their […]
Agreement - February 11, 2015
Novo Joins Research Team
Novo Nordisk and Merck are the newest members of the GPCR Consortium, a global nonprofit researching a little-understood protein. The group, which also includes Amgen, Sanofi and Ono, is concentrating on proteins called G-protein coupled receptors (GPCRs), which play a role in a wide variety of processes in the body. Working with universities in China and […]
